|Table of Contents|

The efficacy of superselective tumor arterial embolization combined with simple posterior approach resection for the treatment of sacral chordoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 08
Page:
1512-1517
Research Field:
Publishing date:

Info

Title:
The efficacy of superselective tumor arterial embolization combined with simple posterior approach resection for the treatment of sacral chordoma
Author(s):
HUANG ChangzhiHUANG ZhaoxiHUANG YufengZENG WeiWEI LinwenLIN Jiuzao
Department of Orthopaedics,Ningde Hospital Affiliated to Ningde Normal University,Fujian Ningde 352000,China.
Keywords:
tumor arterial embolizationsacrumchordomaresection
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2023.08.023
Abstract:
Objective:To investigate the curative effect of surgical resection after tumor arterial embolization for primary sacral chordoma.Methods:30 cases of primary sacrum chordoma treated in our hospital were retrospectively analyzed from January 2012 to January 2018.Superselective tumor arterial embolization under digital subtraction angiography (DSA) was performed preoperatively in 19 cases,then using a posterior approach to remove the tumor completely (group A),while 11 cases only used a posterior approach to remove the tumor completely (group B).Compared the operation time,the intraoperative blood loss,the postoperative drainage blood,the postoperative extubation time,the complication and the postoperative tumor recurrence rate between the two groups.Results:All the patients successfully completed the operation.None of case rectal injury shock or died during operation.The average operation time of group A was (202.42±29.75)min (range:155~248 min),the average intraoperative blood loss of group A was (1 349.84±282.84)mL (range:685~1 885 mL),the average postoperative drainage blood of group A was (227.26±35.82)mL (range:150~300 mL) and the average postoperative extubation time of group A was (7.42±0.61)d (range:7~9 d).The average operation time of group B was (271.45±21.78)min (range:220~300 min),the average intraoperative blood loss of group B was (1 846.45±396.38)mL (range:890~2 400 mL),the average postoperative drainage blood of group B was (284.09±38.26)mL (range:220~330 mL) and the average postoperative extubation time of group B was (9.45±0.69)d (range:8~10 d).The operation time,]intraoperative blood loss and postoperative drainage volume in group A were less than those in group B,and the differences were statistically significant (P<0.001).The complication rate between group A and group B was 26.3% vs 27.3%,and the postoperative tumor recurrence rate between the two groups was 31.6% vs 27.3%.There was no statistically significant difference in the complication rate and postoperative tumor recurrence rate between the two groups (P>0.05).Conclusion:DSA guided superselective tumor arterial embolization combined with simple posterior sacral approach can completely remove primary sacral chordoma in one stage,and achieve satisfactory clinical results.

References:

[1] KAYANIB,HANNASA,SEWELLMD,et al.A review of the surgical management of sacral chordoma[J].Eur J Surg Oncol,2014,40(11):1412-1420.
[2] SMOLL NR,GAUTSCHI OP,RADOVANOVIC I,et al.Incidence and relative survival of chordomas:the standardized mortality ratio and the impact of chordomas on a population[J].Cancer,2013,119(11):2029-2037.
[3] YU E,KOFFER PP,DI PETRILLO TA,et al.Incidence,treatment,and survival patterns for sacral chordoma in the United States,1974-2011[J].Front Oncol,2016,6:203.
[4] TSITOURAS V,WANG S,DIRKS P,et al.Management and outcome of chordomas in the pediatric population:The Hospital for Sick Children experience and review of the literature[J].J Clin Neurosci,2016,34:169-176.
[5] FELDMAN F,CASARELLA WJ,DICK HM,et al.Selective intraarterial embolization of bone tumors:A useful adjunct in the management of selected lesions[J].AJR,1975,123:130.
[6] HULEN CA,TEMPLE HT,FOX WP,et al.Oncologic and functional outcome following sacrectomy for sacral chordoma[J].J Bone Joint Surg Am,2006,88(7):1532-1539.
[7] SIMPSON AH,PORTER A,DAVIS A,et al.Cephalad sacral resection with a combined extended ilioinguinal and posterior approach[J].J Bone Joint Surg Am,1995,77(3):405-411.
[8] LACKMAN RD,KHOURY LD,ESMAIL A,et al.The treatment of sacral giant-cell tumours by serial arterial embolisation[J].J Bone Joint Surg Br,2002,84(6):873-877.
[9] TOMITA K,KAWAHARA N,KOBAYASHI T,et al.Surgical strategy for spinal metastases[J].Spine(Phila Pa 1976),2001,26(3):298-306.
[10] 袁峰,杨惠林.骶骨脊索瘤的治疗进展[J].中国脊柱脊髓杂志,2003,13(12):751-753. YUAN F,YANG HL.Progress in clinical treatment of sacral chordoma[J].Chinese Journal of Spine and Spine Cord,2003,13(12):751-753.
[11] 赵庆和,王田田,张俊丽,等.骶骨脊索瘤术前靶血管栓塞联合术中腹主动脉球囊阻断在临床中的应用[J].医学信息杂志,2014,35(3):169. ZHAO QH,WANG TT,ZHANG JL,et al.Clinical application of preoperative target vessel embolization combined with intraoperative abdominal aortic balloon occlusion in sacral chordoma[J].Medical Information,2014,35(3):169.
[12] 夏侃,王浩.靶血管栓塞在骶骨脊索瘤手术治疗中的应用研究[J].中国中医骨伤科杂志,2013,21(7):47-48. XIA K,WANG H.Application of target vessel embolization in the surgical treatment of sacral chordoma[J].Chinese J Trad Med Traum & Orthop,2013,21(7):47-48.
[13] OZKAN E,GUPTA S.Embolization of spinal tumors:vascular anatomy,indications,and technique[J].Tech Vasc Interv Radiol,2011,14(3):129-140.
[14] YIN H,ZHOU W,MENG J,et al.Prognostic factors of patients with spinal chondrosarcoma:a retrospective analysis of 98 consecutive patients in a single center[J].Ann Surg Oncol,2014,21(11):3572-3578.
[15] GUO W,TANG X,ZANG J,et al.One-stage total en bloc sacrectomy:a novel technique and report of 9 cases[J].Spine (Phila Pa 1976),2013,38(10):E626-E631.
[16] ASAVAMONGKOLKUL A,WAIKAKUL S.Wide resection of sacral chordoma via a posterior approach[J].Int Orthop,2012,36(3):607-612.
[17] WEI R,GUO W,YANG R,et al.Reconstruction of the pelvic ring after total en bloc sacrectomy using a 3D-printed sacral endoprosthesis with re-establishment of spinopelvic stability:a retrospective comparative study[J].Bone Joint J,2019,101(7):880-888.
[18] 姜超,王欢,阎崇楠.单纯后路横切口治疗骶骨肿瘤的临床疗效分析[J].现代肿瘤医学,2021,29(12):2120-2122. JIANG C,WANG H,YAN CN.Clinical analysis of simple posterior transverse incision for the treatment of sacral tumor[J].Modern Oncology,2021,29(12):2120-2122.
[19] 冷傲,矫健,钟哲南,等.脊柱脊索瘤临床治疗进展及展望[J].临床与病理杂志,2018,38(8):1762-1767. LENG A,JIAO J,ZHONG ZN,et al.Progress and perspectives in clinical treatment of spinal chordoma[J].J Clin Pathol Res,2018,38(8):1762-1767.
[20] 袁峰,杨惠林,张志明,等.骶骨脊索瘤的靶血管栓塞和手术治疗[J].脊柱外科杂志,2003,1(2):89-91. YUAN F,YANG HL,ZHANG ZM,et al.Surgical treatment combined with transcatheter arterial embolization for excision of sacral chordoma[J].J Spinal Surg,2003,1(2):89-91.
[21] 陈康武,杨惠林,陆俭,等.靶血管栓塞后手术治疗复发性骶骨脊索瘤的疗效分析[J].中国骨肿瘤骨病杂志,2009,8(6):324-326. CHEN KW,YANG HL,LU J,et al.Surgical treatment of recurring sacral chordoma after target arterial embolization[J].Chin J Bone Tumor & Bone Disease,2009,8(6):324-326.
[22] YANG H,ZHU L,EBRAHEIM NA,et al.Surgical treatment of sacral chordomas combined with transcatheter arterial embolization[J].J Spinal Disord Tech,2010,23(1):47-52.
[23]CLARKE MJ,DASENBROCK H,BYDON A,et al.Posterior-only approach for en bloc sacrectomy:clinical outcomes in 36 consecutive patients[J].Neurosurgery,2012,71(2):357-364.
[24] 孙伟,陈泉池,马小军,等.单纯后路全骶骨切除治疗骶骨恶性肿瘤[J].中华骨科杂志,2014,34(11):1097-1102. SUN W,CHEN QC,MA XJ,et al.Simple posterior total humerus resection for the treatment of sacral malignant tumors[J].Chinese Journal of Orthopaedics,2014,34(11):1097-1102.
[25] TODD LT JR,YASZEMSKI MJ,CURRIER BL,et al.Bowel and bladder function after major sacral resection[J].Clin Orthop Relat Res,2002,397:36-39.
[26] SAMSON IR,SPRINGFIELD DS,SUIT HD,et al.Operative treatment of sacrococcygeal chordoma:A review of twenty-one cases[J].J Bone Joint Surg Am,1993,75(10):1476-1484.
[27] PURI A,AGARWAL MG,SHAH M,et al.Decision making in primary sacral tumors[J].Spine J,2009,9(5):396-403.
[28] HUGATE RR JR,DICKEID,PHIMOLSARNTI R,et al.Mechanical effects of partial sacrectomy:when is reconstruction necessary[J].Clin Orthop Relat Res,2006,450:82-88.
[29] GUNTERBERG B.Effects of major resection of the sacrum:Clinical studies on urogenital and anorectal function and a biomechanical study on pelvic strength[J].Acta Orthop Scand Suppl,1976,162:1-38.

Memo

Memo:
-
Last Update: 1900-01-01